Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Stephan, Bates"'
Autor:
Estefanía García-Guerrero, Luis G. Rodríguez-Lobato, Belén Sierro-Martínez, Sophia Danhof, Stephan Bates, Silke Frenz, Larissa Haertle, Ralph Götz, Markus Sauer, Leo Rasche, K. Martin Kortüm, Jose A. Pérez-Simón, Hermann Einsele, Michael Hudecek, Sabrina R. Prommersberger
Publikováno v:
Haematologica, Vol 108, Iss 2 (2022)
B-cell maturation antigen (BCMA) is the lead antigen for chimeric antigen receptor (CAR) T-cell therapy in multiple myeloma (MM). A challenge is inter- and intra-patient heterogeneity in BCMA expression on MM cells and BCMA downmodulation under thera
Externí odkaz:
https://doaj.org/article/c5afb352d346406386ae305b8e18e44f
Autor:
Mario Assenmacher, Andrew Kaiser, Michael Hudecek, Razieh Monjezi, Matthias Eyrich, Dominik Lock, Caroline Brandes, Stephan Bates, Simon Lennartz, Karin Teppert, Leon Gehrke, Rafailla Karasakalidou-Seidt, Teodora Lukic, Marco Schmeer, Martin Schleef, Niels Werchau, Sabrina Prommersberger, Thomas Schaser
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)
Background There is an increasing demand for chimeric antigen receptor (CAR) T cell products from patients and care givers. Here, we established an automated manufacturing process for CAR T cells on the CliniMACS Prodigy platform that is scaled to pr
Externí odkaz:
https://doaj.org/article/a0271935abc24905bcbae8721e14d36f
Autor:
Estefanía, García-Guerrero, Luis G, Rodríguez-Lobato, Belén, Sierro-Martínez, Sophia, Danhof, Stephan, Bates, Silke, Frenz, Larissa, Haertle, Ralph, Götz, Markus, Sauer, Leo, Rasche, K Martin, Kortüm, Jose A, Pérez-Simón, Hermann, Einsele, Michael, Hudecek, Sabrina R, Prommersberger
Publikováno v:
Haematologica.
B-cell maturation antigen (BCMA) is the lead antigen for CAR T-cell therapy in multiple myeloma (MM). A challenge is inter- and intra-patient heterogeneity in BCMA expression on MM cells and BCMA downmodulation under therapeutic pressure. Accordingly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8cff22f1d3748edc0be8916035a068e4
https://pubmed.ncbi.nlm.nih.gov/36047086
https://pubmed.ncbi.nlm.nih.gov/36047086
Autor:
Dominik Lock, Razieh Monjezi, Caroline Brandes, Stephan Bates, Simon Lennartz, Karin Teppert, Leon Gehrke, Rafailla Karasakalidou-Seidt, Teodora Lukic, Marco Schmeer, Martin Schleef, Niels Werchau, Matthias Eyrich, Mario Assenmacher, Andrew Kaiser, Sabrina Prommersberger, Thomas Schaser, Michael Hudecek
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e005189
BackgroundThere is an increasing demand for chimeric antigen receptor (CAR) T cell products from patients and care givers. Here, we established an automated manufacturing process for CAR T cells on the CliniMACS Prodigy platform that is scaled to pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb52d73c4a07650f24141fa537604109
https://doi.org/10.1136/jitc-2022-005189
https://doi.org/10.1136/jitc-2022-005189